DREIMT: a drug repositioning database and prioritization tool for immunomodulation

Area of Science:

• Immunology
• Pharmacology
• Bioinformatics

Background:

• Drug immunomodulation is a therapeutic strategy for diseases like cancer and autoimmune disorders.
• Identifying effective immunomodulatory drugs requires sophisticated analysis of complex biological data.

Purpose of the Study:

• To introduce DREIMT, a new hypothesis-generation web tool for drug prioritization in immunomodulation.
• To provide a resource for identifying potential immunomodulatory drugs targeting specific immune cell subtypes and gene expression signatures.

Main Methods:

• DREIMT utilizes a curated database integrating 4960 drug profiles and approximately 2600 immune gene expression signatures.
• The tool performs drug prioritization analysis for immunomodulation, targeting up to 70 immune cell subtypes.
• It also suggests drugs based on user-supplied gene expression signatures.

Main Results:

• DREIMT provides significant immunomodulatory drug candidates.
• The tool outputs drug-signature association scores and False Discovery Rates (FDRs).
• Results include downloadable plots and data tables for further analysis.

Conclusions:

• DREIMT facilitates hypothesis generation for drug immunomodulation research.
• The tool aids in discovering novel therapeutic strategies for immune-related diseases.
• DREIMT is a valuable resource for researchers in immunology and pharmacology.